PTGDR2 and gastric cancer: Fukuoka et al. [75] indicated that in 277 gastric cancer patients, 55% had PTGDR2 (including DP1) expression in cancerous tissues, which significantly correlated with lymph node metastasis, lymphovascular infiltration, and tumor, node, metastasis (TNM) stage.